secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neumora Therapeutics, Inc. (NMRA)
CIK:        0001885522
Form:       8-K
Filed at:   2026-10-30T20:05:16+00:00
Accession:  0001193125-26-441634
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Neumora gets Nasdaq bid-price notice; 180 days to regain $1.00 compliance by April 26, 2027
--------------------------------------------------------------------------------

- Nasdaq notified Neumora on October 26, 2026 that its common stock is below the $1.00 minimum bid price under Listing Rule 5450(a)(1).
- Company has until April 26, 2027; shares must close at or above $1.00 for at least 10 consecutive business days to cure.
- If not cured, Neumora could apply to transfer to the Nasdaq Capital Market for additional time, subject to other listing standards and a fee.
- Neumora said it will monitor its bid price and consider options including a reverse stock split; no assurance of compliance was given.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1885522/000119312526441634/0001193125-26-441634-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1885522/000119312526441634/d128962d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-441634

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer